Where can you get Botox? Every treatment area on the face and body

Botox Cosmetic is approved in adults for the temporary improvement in the appearance of four areas: moderate to severe frown lines (glabellar lines, or the 11s), crow's feet (lateral canthal lines), forehead lines and platysma bands (vertical neck bands).

No other cosmetic area is on the label.

The frown-line indication came first of the four, with FDA approval on April 12, 2002. Crow's feet followed on September 11, 2013, and the forehead-lines indication on October 2, 2017.

The fourth labeled area, the platysma bands of the neck, came later still and is covered in the neck section below.

Each labeled area carries a fixed dose in the label:

• Frown lines. 20 units, given as 4 units into each of 5 sites — two in each corrugator muscle and one in the procerus.
• Crow's feet. 24 units in total: 12 units per side, delivered as 4 units into each of 3 sites around the outer eye.
• Forehead lines. No forehead-only dose. The label treats forehead lines together with the frown lines — 20 units to the forehead plus 20 units to the glabella, 40 units in total — to minimize the risk of a dropped brow.
• All three upper-face areas in one session. 64 units; frown lines plus crow's feet, without the forehead, is 44 units.

Those are Botox Cosmetic numbers, and Botox Cosmetic units are product-specific: the label states they cannot be compared to or converted into units of any other botulinum toxin product. Dysport's only US cosmetic indication is frown lines, and only in adults younger than 65 — its label has no crow's-feet or forehead-lines indication. Xeomin covers all three upper-face areas; its label was expanded in July 2024 to cover the glabella, horizontal forehead lines and crow's feet together, at up to 64 units.

A chemical brow lift — Botox placed to raise the eyebrows rather than to soften lines — is a different goal, and Cleveland Clinic describes it as an off-label use, along with treatment of lip lines and neck laxity.

We could not find a label, consensus statement or high-quality study that gives a unit range for a brow lift; any dose a provider quotes for it is that injector's own.

Below the eyes, the label stops.

No current US neurotoxin label lists the mid-face requests — bunny lines (the short diagonal lines that appear on the sides of the nose when you scrunch it), a nose injection meant to lift or refine the tip, or Botox under the eyes — for Botox or for any other brand.

Off-label here means the area is missing from the label, not that a different drug is used.

It is the same Botox Cosmetic, placed outside the four areas its label covers.

In the lower face, every area is off-label.

Cleveland Clinic's list of the off-label Botox uses it offers includes raising the corners of the mouth, softening lip creases, lip lengthening for a gummy smile, and chin softening for what it calls the “peach-pit chin”.

The DAO — the depressor anguli oris, the muscle that pulls the mouth corners down — is the muscle behind the marionette-lines request.

Lifting the mouth corners is off-label, and no US label lists the DAO.

Chin softening is off-label too.

So are jowls and the Nefertiti lift, a jawline-and-neck technique: not on any current US label, and we could not find published unit ranges for any of these areas, so the doses are the injector's own.

The lip flip everts (rolls out) the upper lip by relaxing the orbicularis oris, the muscle that rings the mouth.

It adds no volume — that is what lip filler does — and no US neurotoxin label includes the lips.

A 2025 systematic review reported that a lip flip typically uses 4 to 6 units into the orbicularis oris, with mild, transient after-effects such as temporary difficulty whistling or drinking through a straw.

Gummy smile work targets the muscles that lift the lip.

A 2024 systematic review of 13 controlled trials found the effect peaked at 2 to 4 weeks and lasted up to 12 to 24 weeks; the muscles most often targeted were the levator labii superioris alaeque nasi, the levator labii superioris and the zygomaticus minor.

A 2023 meta-analysis reported doses of 1.25 to 7.5 units per side and a reduction in gum show of up to 6 mm at 12 weeks.

Those are study figures for the people studied — not label doses, and not a prediction for any one person.

The masseter — the muscle at the back angle of the jaw — rounds out the lower face.

Jaw slimming with masseter Botox is off-label in the US: the current Botox Cosmetic label, published in 2026, does not list masseter prominence, although AbbVie has run phase 2 and phase 3 trials of onabotulinumtoxinA for the jaw muscle.

AbbVie's phase 3 trial used 72 units in 376 adults, measured results at day 90 and found improvements holding through day 180.

The neck is where Botox's newest labeled area sits.

Platysma bands — the vertical bands that run from the jawline down the neck — were added to the Botox Cosmetic label on October 18, 2024, which makes Botox Cosmetic the only US neurotoxin currently labeled for neck bands.

The labeled dose is 26, 31 or 36 units, depending on how many bands are present (one or two per side), split between injections along the jawline and along each band.

The rest of the neck is off-label: the Nefertiti lift, jowl work and broader neck-loosening techniques are not on any current US label, and we could not find published unit ranges for them.

The on-label part of the neck is the vertical platysma bands specifically.

The trapezius — the muscle that caps the shoulder, marketed as “traptox” — is off-label as well: no US toxin label lists it.

Under the arms, the story changes.

Botox (the therapeutic product, not Botox Cosmetic) is approved for severe primary axillary hyperhidrosis — underarm sweating that topical agents have not adequately managed.

The labeled dose is 50 units per armpit, 100 units in total.

Botox and Botox Cosmetic contain the same active ingredient in the same formulation; what differs is the labeled indications.

For sweating in other body areas — the palms, the feet, the face — the label states that safety and effectiveness have not been established.

Four cosmetic areas carry a dose on the Botox Cosmetic label, therapeutic Botox sets a fifth — underarm sweating — and the off-label areas carry none, which is why unit counts, and prices, are easy to compare within the label and hard to compare outside it.

The labeled doses in the table come from the Botox Cosmetic and therapeutic Botox labels, and Botox units do not transfer between brands: the Botox Cosmetic label states its units cannot be compared to or converted into units of any other botulinum toxin product, and Dysport's label says the same.

The doses can look very different for the same area — Dysport's labeled frown-line dose is 50 units, given as five 10-unit injections, against Botox Cosmetic's 20 units.

Practices typically price Botox per unit or per treatment area, and the label doses act as a floor for the unit count an area needs, so an area's price is roughly units times the practice's per-unit price.

We could not confirm a current national average price for neuromodulator injections — the ASPS statistics report for 2025 that we checked omits fees for minimally invasive procedures.

Ask each practice you are considering for its per-unit price and how many units it plans to use in each area, so quotes can be compared like for like.